These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2672427)

  • 1. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.
    Steinberg GK; Saleh J; Kunis D; DeLaPaz R; Zarnegar SR
    Stroke; 1989 Sep; 20(9):1247-52. PubMed ID: 2672427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; Saleh J; DeLaPaz R; Kunis D; Zarnegar SR
    Brain Res; 1989 Sep; 497(2):382-6. PubMed ID: 2684345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; George CP; DeLaPaz R; Shibata DK; Gross T
    Stroke; 1988 Sep; 19(9):1112-8. PubMed ID: 3413809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP; Goldberg MP; Choi DW; Steinberg GK
    Brain Res; 1988 Feb; 440(2):375-9. PubMed ID: 3359222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK; Yoon EJ; Kunis DM; Sun GH; Maier CM; Grant GA
    Neuroscience; 1995 Jan; 64(1):99-107. PubMed ID: 7708219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK; Kunis D; DeLaPaz R; Poljak A
    Neurol Res; 1993 Jun; 15(3):174-80. PubMed ID: 8103583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons.
    Choi DW; Peters S; Viseskul V
    J Pharmacol Exp Ther; 1987 Aug; 242(2):713-20. PubMed ID: 3039122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices.
    Wong BY; Coulter DA; Choi DW; Prince DA
    Neurosci Lett; 1988 Feb; 85(2):261-6. PubMed ID: 2897648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity.
    Choi DW
    Brain Res; 1987 Feb; 403(2):333-6. PubMed ID: 2881608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
    Aram JA; Martin D; Tomczyk M; Zeman S; Millar J; Pohler G; Lodge D
    J Pharmacol Exp Ther; 1989 Jan; 248(1):320-8. PubMed ID: 2536430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture.
    Goldberg MP; Pham PC; Choi DW
    Neurosci Lett; 1987 Sep; 80(1):11-5. PubMed ID: 3658226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan inhibits NMDA-induced convulsions.
    Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
    Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextromethorphan attenuates post-ischemic hypoperfusion following incomplete global ischemia in the anesthetized rat.
    Tortella FC; Martin DA; Allot CP; Steel JA; Blackburn TP; Loveday BE; Russell NJ
    Brain Res; 1989 Mar; 482(1):179-83. PubMed ID: 2706475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice.
    Leander JD
    Epilepsy Res; 1989; 4(1):28-33. PubMed ID: 2666123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
    Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
    J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of morphinan drugs on haloperidol-induced catalepsy in rats: a comparative study with an N-methyl-D-aspartate antagonist.
    Scotti de Carolis A; Popoli P; Pezzola A; Sagratella S
    Arch Int Pharmacodyn Ther; 1991; 310():132-41. PubMed ID: 1685312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters.
    Richter A; Löscher W
    Brain Res; 1997 Jan; 745(1-2):336-8. PubMed ID: 9037429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.